S. Yang

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin-naive patients with extensive-disease small cell lung cancer (Cancer (2009) 116, (132-136))

Dong Han Lee, M. Ahn, C. Suh, 2010 .

Association of the CD14 gene –159C polymorphism with progression of IgA nephropathy

H. Yoon, Y. Kim, D. Chae, 2003, Journal of medical genetics.

Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).

E. Baba, C. Yoo, Yoon-Koo Kang, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Differential expression of various cytokine and chemokine genes between proliferative and non-proliferative glomerulonephritides.

D. Chae, J. S. Lee, C. Lim, 2001, Clinical nephrology.

A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer

Young-Ae Park, B. Ryoo, S. Yang, 2006, British Journal of Cancer.

Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients

Y. Bang, D. Heo, Y. Do, 2006, Annals of Hematology.

Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials.

Ya-li Liu, B. Ma, Y. P. Li, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Proteins involved in DNA damage response pathways and survival of stage I non-small-cell lung cancer patients.

Y. T. Kim, D. Kim, S. Jang, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Erythroid/B-cell biphenotypic acute leukemia first case report

Y. Zou, S. Yang, J. Lee, 2009, Leukemia.

Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials.

Ya-li Liu, B. Ma, Y. P. Li, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.